X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse SUVEN LIFE with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFESCIENCES   ADCOCK INGRAM
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
ADCOCK INGRAM
Jun-14
SUVEN LIFESCIENCES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs338340-   
Low Rs169245-   
Sales per share (Unadj.) Rs52.1101.1-  
Earnings per share (Unadj.) Rs6.8-25.5-  
Cash flow per share (Unadj.) Rs8.6-21.1-  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.379.4-  
Shares outstanding (eoy) m127.28168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.9 168.1%   
Avg P/E ratio x37.1-11.5 -323.3%  
P/CF ratio (eoy) x29.6-13.9 -213.5%  
Price / Book Value ratio x3.93.7 105.3%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,27249,394 65.3%   
No. of employees `0001.14.3 25.2%   
Total wages/salary Rs m6613,100 21.3%   
Avg. sales/employee Rs Th6,132.23,976.6 154.2%   
Avg. wages/employee Rs Th611.1722.1 84.6%   
Avg. net profit/employee Rs Th803.5-1,002.0 -80.2%   
INCOME DATA
Net Sales Rs m6,63517,072 38.9%  
Other income Rs m242120 202.7%   
Total revenues Rs m6,87717,191 40.0%   
Gross profit Rs m1,604-2,958 -54.2%  
Depreciation Rs m221737 30.0%   
Interest Rs m38462 8.2%   
Profit before tax Rs m1,587-4,038 -39.3%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718252 284.6%   
Profit after tax Rs m869-4,302 -20.2%  
Gross profit margin %24.2-17.3 -139.5%  
Effective tax rate %45.2-6.2 -723.9%   
Net profit margin %13.1-25.2 -52.0%  
BALANCE SHEET DATA
Current assets Rs m6,23212,504 49.8%   
Current liabilities Rs m1,4907,035 21.2%   
Net working cap to sales %71.532.0 223.1%  
Current ratio x4.21.8 235.3%  
Inventory Days Days86111 77.9%  
Debtors Days Days83124 66.6%  
Net fixed assets Rs m4,0437,288 55.5%   
Share capital Rs m12779 160.6%   
"Free" reserves Rs m8,1830-   
Net worth Rs m8,31013,399 62.0%   
Long term debt Rs m184,709 0.4%   
Total assets Rs m10,38925,312 41.0%  
Interest coverage x43.1-7.7 -557.5%   
Debt to equity ratio x00.4 0.6%  
Sales to assets ratio x0.60.7 94.7%   
Return on assets %8.7-15.2 -57.6%  
Return on equity %10.5-32.1 -32.6%  
Return on capital %19.5-19.8 -98.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,8220-   
CASH FLOW
From Operations Rs m3561,457 24.4%  
From Investments Rs m-279-447 62.3%  
From Financial Activity Rs m-2254,274 -5.3%  
Net Cashflow Rs m-1485,283 -2.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.69 Rs / ZAR

Compare SUVEN LIFESCIENCES With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SUVEN LIFESCIENCES With: BIOCON   WOCKHARDT  DR. REDDYS LAB  ALKEM LABORATORIES  DIVIS LABORATORIES  



Today's Market

Dividend Stocks Amid Volatile Stock Markets; US-China Trade War and More(Podcast)

The market, which has been caught in the grip of the bears, gave a negative yearly return for first time in last eight years.

Related Views On News

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

More Views on News

Most Popular

7 Stocks to Buy in Today's Difficult Market (The 5 Minute Wrapup)

Aug 5, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

The Perfect Stock in the Rebirth of India (The 5 Minute Wrapup)

Aug 8, 2019

This debt-free, well-managed company is all set to soar.

My Top 3 Dividend Millionaire Stocks (Profit Hunter)

Aug 7, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

This 60-Year Old Smallcap Company Could Be Our Next Recommendation (The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Aug 16, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS